Secreted human glycyl-tRNA synthetase implicated in defense against ERK-activated tumorigenesis

Min Chul Park, Taehee Kang, Da Jin, Jung Min Han, Sang Bum Kim, Yun Jung Park, Kiwon Cho, Young Woo Park, Min Guo, Weiwei He, Xiang Lei Yang, Paul Schimmel, Sunghoon Kim

Research output: Contribution to journalArticle

65 Citations (Scopus)

Abstract

Although adaptive systems of immunity against tumor initiation and destruction are well investigated, less understood is the role, if any, of endogenous factors that have conventional functions. Here we show that glycyl-tRNA synthetase (GRS), an essential component of the translation apparatus, circulates in serum and can be secreted from macrophages in response to Fas ligand that is released from tumor cells. Through cadherin (CDH)6 (K-cadherin), GRS bound to different ERK-activated tumor cells, and released phosphatase 2A (PP2A) from CDH6. The activated PP2A then suppressed ERK signaling through dephosphorylation of ERK and induced apoptosis. These activities were inhibited by blocking GRS with a soluble fragment of CDH6. With in vivo administration of GRS, growth of tumors with a high level of CDH6 and ERK activation were strongly suppressed. Our results implicate a conventional cytoplasmic enzyme in translation as an intrinsic component of the defense against ERK-activated tumor formation.

Original languageEnglish
Pages (from-to)E640-E647
JournalProceedings of the National Academy of Sciences of the United States of America
Volume109
Issue number11
DOIs
Publication statusPublished - 2012 Mar 13

Fingerprint

Glycine-tRNA Ligase
Carcinogenesis
Neoplasms
Phosphoric Monoester Hydrolases
Fas Ligand Protein
Adaptive Immunity
Macrophages
Apoptosis
Enzymes
Growth
Serum

All Science Journal Classification (ASJC) codes

  • General

Cite this

Park, Min Chul ; Kang, Taehee ; Jin, Da ; Han, Jung Min ; Kim, Sang Bum ; Park, Yun Jung ; Cho, Kiwon ; Park, Young Woo ; Guo, Min ; He, Weiwei ; Yang, Xiang Lei ; Schimmel, Paul ; Kim, Sunghoon. / Secreted human glycyl-tRNA synthetase implicated in defense against ERK-activated tumorigenesis. In: Proceedings of the National Academy of Sciences of the United States of America. 2012 ; Vol. 109, No. 11. pp. E640-E647.
@article{0b5c8c4fbeee4f04883db7e5384a666a,
title = "Secreted human glycyl-tRNA synthetase implicated in defense against ERK-activated tumorigenesis",
abstract = "Although adaptive systems of immunity against tumor initiation and destruction are well investigated, less understood is the role, if any, of endogenous factors that have conventional functions. Here we show that glycyl-tRNA synthetase (GRS), an essential component of the translation apparatus, circulates in serum and can be secreted from macrophages in response to Fas ligand that is released from tumor cells. Through cadherin (CDH)6 (K-cadherin), GRS bound to different ERK-activated tumor cells, and released phosphatase 2A (PP2A) from CDH6. The activated PP2A then suppressed ERK signaling through dephosphorylation of ERK and induced apoptosis. These activities were inhibited by blocking GRS with a soluble fragment of CDH6. With in vivo administration of GRS, growth of tumors with a high level of CDH6 and ERK activation were strongly suppressed. Our results implicate a conventional cytoplasmic enzyme in translation as an intrinsic component of the defense against ERK-activated tumor formation.",
author = "Park, {Min Chul} and Taehee Kang and Da Jin and Han, {Jung Min} and Kim, {Sang Bum} and Park, {Yun Jung} and Kiwon Cho and Park, {Young Woo} and Min Guo and Weiwei He and Yang, {Xiang Lei} and Paul Schimmel and Sunghoon Kim",
year = "2012",
month = "3",
day = "13",
doi = "10.1073/pnas.1200194109",
language = "English",
volume = "109",
pages = "E640--E647",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "11",

}

Park, MC, Kang, T, Jin, D, Han, JM, Kim, SB, Park, YJ, Cho, K, Park, YW, Guo, M, He, W, Yang, XL, Schimmel, P & Kim, S 2012, 'Secreted human glycyl-tRNA synthetase implicated in defense against ERK-activated tumorigenesis', Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 11, pp. E640-E647. https://doi.org/10.1073/pnas.1200194109

Secreted human glycyl-tRNA synthetase implicated in defense against ERK-activated tumorigenesis. / Park, Min Chul; Kang, Taehee; Jin, Da; Han, Jung Min; Kim, Sang Bum; Park, Yun Jung; Cho, Kiwon; Park, Young Woo; Guo, Min; He, Weiwei; Yang, Xiang Lei; Schimmel, Paul; Kim, Sunghoon.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 109, No. 11, 13.03.2012, p. E640-E647.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Secreted human glycyl-tRNA synthetase implicated in defense against ERK-activated tumorigenesis

AU - Park, Min Chul

AU - Kang, Taehee

AU - Jin, Da

AU - Han, Jung Min

AU - Kim, Sang Bum

AU - Park, Yun Jung

AU - Cho, Kiwon

AU - Park, Young Woo

AU - Guo, Min

AU - He, Weiwei

AU - Yang, Xiang Lei

AU - Schimmel, Paul

AU - Kim, Sunghoon

PY - 2012/3/13

Y1 - 2012/3/13

N2 - Although adaptive systems of immunity against tumor initiation and destruction are well investigated, less understood is the role, if any, of endogenous factors that have conventional functions. Here we show that glycyl-tRNA synthetase (GRS), an essential component of the translation apparatus, circulates in serum and can be secreted from macrophages in response to Fas ligand that is released from tumor cells. Through cadherin (CDH)6 (K-cadherin), GRS bound to different ERK-activated tumor cells, and released phosphatase 2A (PP2A) from CDH6. The activated PP2A then suppressed ERK signaling through dephosphorylation of ERK and induced apoptosis. These activities were inhibited by blocking GRS with a soluble fragment of CDH6. With in vivo administration of GRS, growth of tumors with a high level of CDH6 and ERK activation were strongly suppressed. Our results implicate a conventional cytoplasmic enzyme in translation as an intrinsic component of the defense against ERK-activated tumor formation.

AB - Although adaptive systems of immunity against tumor initiation and destruction are well investigated, less understood is the role, if any, of endogenous factors that have conventional functions. Here we show that glycyl-tRNA synthetase (GRS), an essential component of the translation apparatus, circulates in serum and can be secreted from macrophages in response to Fas ligand that is released from tumor cells. Through cadherin (CDH)6 (K-cadherin), GRS bound to different ERK-activated tumor cells, and released phosphatase 2A (PP2A) from CDH6. The activated PP2A then suppressed ERK signaling through dephosphorylation of ERK and induced apoptosis. These activities were inhibited by blocking GRS with a soluble fragment of CDH6. With in vivo administration of GRS, growth of tumors with a high level of CDH6 and ERK activation were strongly suppressed. Our results implicate a conventional cytoplasmic enzyme in translation as an intrinsic component of the defense against ERK-activated tumor formation.

UR - http://www.scopus.com/inward/record.url?scp=84863251058&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863251058&partnerID=8YFLogxK

U2 - 10.1073/pnas.1200194109

DO - 10.1073/pnas.1200194109

M3 - Article

C2 - 22345558

AN - SCOPUS:84863251058

VL - 109

SP - E640-E647

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 11

ER -